- The subject has a known immediate or delayed hypersensitivity reaction or idiosyncrasy to drugs chemically related to randomized therapy (GW572016 or placebo) or to excipients of randomized therapy (GW572016 or placebo); 18. Subject has known hypersensitivity to Femara or excipients of Femara